A Clinical Study of Allogeneic Human Dermal Fibroblasts for Remodeling Scar Contractures
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety of ICX-RHY-013 in the treatment
of stable, restrictive scars in subjects who have suffered a burn injury. Evaluation will be
achieved through regular assessment of adverse events, vital signs, blood work monitoring and
laboratory analysis cellular properties of the scar through biopsy.
The secondary objectives of this study are to evaluate improvement in symptoms of scars
including reduced pain, discomfort and itching, improvement in mobility and daily function,
improvement in appearance and scar texture.